| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 869 | 0 | 869 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| BRISTOL MYERS SQUIBB | 4,593,158 | 10,293,920 |
| FATE THERAPEUTICS | 342,796 | 24,750 |
| FIBROGEN INC | 1,019,649 | 15,885 |
| GERON CORP | 59,000 | 70,800 |
| NEUROCRINE BIOSCIENCES | 5,887,440 | 17,472,000 |
| VOYAGER THERAPEUTICS | 90,778 | 85,050 |
| AMICUS THERAPEUTICS INC | 480,246 | 367,380 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL TAX PAYMENT | 19,449 | 0 | 0 |